Success Stories: With Premium Processing Upgrade, NIW Approval Won for a Pulmonary and Critical Care Fellow from India, Credit Goes to Our Team at NAILG

Posted by wegreened on April 19, 2023 in NIW, General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry)

On February 22^nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Pulmonary and Critical Care Fellow in the Field of Pulmonary Medicine (Approval Notice).

General Field: Pulmonary Medicine

Position at the Time of Case Filing: Pulmonary and Critical Care Fellow

Country of Origin: India

State of Residence at the Time of Filing: Wisconsin

Approval Notice Date: February 22^nd, 2023

Processing Time: 4 months, 24 days (Premium Processing Requested)

Case Summary:

The following is the list of items collected for the National Interest Waiver application of an Indian pulmonary and critical care fellow in pulmonary medicine:

Armed with an M.D. in pulmonary medicine, she was working as a critical care fellow at the time of her application with us.
As an expert in the field, her proposed endeavor was to work on characterizing lung disease processes in order to develop protocols to treat them in hospital and clinical settings.
Her research advancing her proposed endeavor was of great importance because it immediately impacts the millions of global citizens who have been diagnosed with either lung cancer or acute myeloid leukemia.
Her proposed endeavor also has broad implications for the United States since two major lung-related concerns currently impacting the American people are COVID-19 and the excessive use of electronic cigarettes. Fortunately, she has provided a blueprint for clinicians who are met with these unique lung complications associated with both COVID-19 and e-cigarette usage, laying the groundwork for effective treatment strategies.
This is why one of her 2 recommenders wrote:

“[The client] is actively protecting vulnerable members of our society by studying these complications in order to more accurately anticipate complications and therefore effectively treat them. Her contributions make her an asset to the American healthcare industry.”

She has also been invited to conduct peer reviews for multiple journals and has completed at least 3 reviews to date.
Her research has resulted in 15 peer-reviewed journal articles (6 of them first-authored). And these publications have been cited a total of 125 times according to Google Scholar.
She has also pursued research directly related to her proposed endeavor of characterizing lung disease processes in order to develop protocols to treat them in hospitals and clinical settings in clinical settings for 8 years.

All of these factors were woven into her petition and presented before the adjudicating authorities at the USCIS. Soon with the help of premium processing, she obtained her approval. We are grateful to her for working with our team and we wish her the best in her future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%